Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

EXPE · Expedia Group, Inc.

$276.88 +1.57% Sep 10 close
Detected setup Wyckoff SOS · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about EXPE

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$EXPE

Expedia Group, Inc.

Expedia Group, Inc. is a large-cap Other Consumer Services company in the Consumer Services sector with a market cap of $31B.

Consumer Services Other Consumer Services stock Stage 2 · Advancing Base 2
$276.88 latest close
Historical record

No active setup in the latest scan — this page shows the last detection Legend AI made for $EXPE. Every level, score and criterion below is computed from the Sep 10 close session (1 session old), and may no longer hold.

Historical verdict · setup score 55/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

EXPE+1.57%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. +2.17 points vs SPY.

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close+1.57% From the open+2.70% Range position57% GapNo gap
QQQ confirmationDiverging (-1.06%) SMH confirmationDiverging (-2.44%)
Short-term conviction -1 points.
  • QQQ, SMH moved against the stock — no index confirmation.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $276.88 +1.6% Sep 10 close
52W High $342.00 19.0% below high
Wks Since High 2w
Base Depth 23.6%
RS Rank 64 percentile of scan
SMA 50 $295.53
Avg Vol 1,590,712
Rel Vol (Sep 10) 1.13×
More stats
52W Low $185.34
Tight Wks 0
Base B2
SMA 200 $259.24
RS Line vs High -14.6%
RS Line Slope -4.8% ▼
ADR% 3.9%
ATR(14) $13.42 (4.8%)
Vol Pace (live) N/A
U/D Vol 0.68
A/D Days 14A / 15D
A/D Rating D
VDU Bars 0/10 d
Position in 52-week range 58thpercentile of the 52-week range
$185.34low
$342.00high

EXPE Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for EXPE.

Create Free Account

Technical Analysis Report Card

$EXPE · $276.88 · as of 2026-09-10 · multi-factor read
49
/ 100
Technicals 49/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$295.53 ↓
100-day$266.34 ↑
200-day$259.24 ↑
Bullish (50 > 200)

RSI (14)

Reading36.7 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateBearish
Histogram-7.770

Bearish — MACD below its signal line and below zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width4% · 26.0%

Near the lower band — under pressure or oversold.

Volume · Buyer vs Seller

Up/Down vol0.68 · Neutral
Rel volume1.13×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.

Support & Resistance

R · $279.76swing level
R · $331.31swing level
R · $342.0052-week high
Price · $276.88now
S · $252.39swing level
S · $233.50swing level
S · $217.42swing level

Fibonacci · Uptrend swing

23.6%$309.99
38.2%$290.18
50.0% ◄ price here$274.18
61.8%$258.17
78.6%$235.38

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for EXPE — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about EXPE
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 4 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini D

Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $298.04, MA150 $253.34, MA200 $258.69
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $294.73, MA150 $253.34, MA200 $258.69
Failing evidence
1.2 150-day MA > 200-day MAMA150 $253.34 vs MA200 $258.69
2. Quarterly EPS growth ≥ 25%From SEPA scan
7/13 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high12.8% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 3.91%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%CANSLIM grade C
L: RS rank ≥ 80 (IBD leadership)RS rank 70
2/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $298.04 vs MA200 $258.69
Failing evidence
Volume expansion above averageVolume ratio 1.21x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$298.04
Relative strengthRS 70
Failing evidence
Volume vs average1.21x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$298.04
Relative strengthRS 70
Failing evidence
Volume vs average1.21x
Box top broken on heavy volumeNot confirmed
4/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$298.04
Relative strengthRS 70
Failing evidence
Volume vs average1.21x
Sign of Strength confirmed on expanding volume1.21x average volume — needs ≥1.4x
4/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
111RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +6 D
A: 22 D: 16 Net: +665 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C 2/7 criteria
Separate score from the Minervini Trend Template (5/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY +8%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 70
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -19.0%

Method Playbook

Trade it like Weinstein EXACT LEVELS · PRO
Weinstein C · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis (historical)

Wyckoff SOS Historical replay: +20% before −8% within 40 sessions: 27% (n=71) · source bars 2025-03-17–2026-09-04 · avg +4.1% per setup (+0.52R) ⚠ Extended past buy zone ⚠ Not actionable yet
55 setup score
RS Score 70
Trend template 5/8
CANSLIM 62.9* (C)
range low: 219.084 range high: 263.745 range pct: 0.204 sos thrust: 0.154 sos vol ratio: 1.386 sos bars ago: 3 near lps: ✗ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS · schematic

SOS: breakout above range_high=263.75, thrust=15.4%, vol=1.4x avg, lps=extended, 3 bars ago | Strong trend (7/8) | Good RS (70) | Moderate pattern (63%) | Stage 2 | Readiness 59/100 (early) | CANSLIM 62.9 (C) | ⚠ Extended past buy zone; Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • Risk is defined — not met No stop — undefined risk
  • A relative-strength leader — partly met RS rank 64 — middling
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 1.1× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 5/8
Why these seven? → The Universal Edge

Minervini Trend Template

5/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $276.88 vs SMA150 $253.85 / SMA200 $259.24
SMA 150 above SMA 200 SMA150 $253.85 vs SMA200 $259.24
SMA 200 trending up Slope +7.71 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $295.53
Price above SMA 50 $276.88 vs SMA50 $295.53
30%+ above 52-week low +49.4% from $185.34
Within 25% of 52-week high -19.0% from $342.00
RS score above 70 RS 70

Fundamentals

52W Range
58%
Mkt Cap SEC
31.2B
Rev YoY
+8%
EPS TTM
$9.81
P/E TTM
28.2x
Float
114M

Company

Company profile
Expedia Group, Inc.
EXPE · NASDAQ · Consumer Services · Other Consumer Services
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
C 62.9* CANSLIM * disqualified on M
C · Curr. EPS
40
A · Annual EPS
64
N · New Highs
40
S · Supply/Demand
100
L · Leader RS
70
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
84
W. Support
$206.35
W. Resist
$342.00
Weekly Structure

Get the full picture on EXPE

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial